Clinical outcomes in patients with piperacillin/tazobactam-non-susceptible but ceftriaxone-susceptible E. coli or K. pneumoniae bloodstream infection.
Ahmad MouradAlison G SmithJesse D TroyThomas L HollandRebekah H WrennNicholas A TurnerPublished in: The Journal of antimicrobial chemotherapy (2024)
These findings suggest that ceftriaxone can be used to effectively treat bloodstream infections with E. coli or K. pneumoniae that are non-susceptible to piperacillin/tazobactam but susceptible to ceftriaxone.
Keyphrases